This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The new horizons of advanced imaging, especially in oncology, must increasingly consider not only diagnostic efficacy but also sustainability for patients, prize-winning researchers told ECR 2025 delegates. Whole-body MRI is emerging as a superior tool for assessing bone marrow and monitoring therapy response in advanced breast cancer.
Moreover, the approach could help detect disease that other effective prostate cancer PET radiotracers may miss, said Heying Duan, MD, a nuclear medicine research scientist at Stanford University, during a November 26 scientific session. Patients were eligible if they were older than 18 and had rising blood levels of PSA ( ≥ 0.2
PET/CT imaging with a new gallium-68-based prostate cancer radiotracer shows promise for detecting recurrent metastatic disease, according to a study published February 20 in the Journal of Nuclear Medicine. The finding is from a phase I/II clinical trial in the U.S. The full study is available here.
Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. It certainly doesn't help matters that the disease has been linked to gadolinium-based contrast agents, a ubiquitous tool in the MR armamentarium. In 2006 the U.S. Louis hospital.
The degree of elevation does not predict disease severity. CRP concentration rise and fall quicker than ESR, often used to guide treatment Blood Cultures – an important element in management and treatment Blood culture positivity often decides whether a patient will require a bone biopsy. ESR and CRP are sensitive, yet not specific.
3-Phase BoneScan A 3-phase bonescan is used to diagnose abnormal areas within the bones or joints, such as a fracture, bone pain, infection, or bonedisease, which cannot be seen successfully with a standard X-ray.
Technetium-99m (Tc-99m) methyl diphosphonate (MDP) bonescans are a potentially viable noninvasive option for diagnosing calciphylaxis, according to a team at the University of Massachusetts in Worcester, MA. The team assessed the potential diagnostic utility of bonescans in calciphylaxis based on a review of the literature.
Bonescan shows diffuse uptake in the markedly enlarged right breast secondary to increased blood pool activity and impaired washout. Bonescan showed diffuse uptake in the markedly enlarged right breast secondary to increased blood pool activity and impaired washout. Mammogram CC view. Breast Cancer. 2012;19(4):289-294.
A doctor will often use a diagnostic imaging test to check patients for signs of cancer. Here is a breakdown of how these methods of diagnostic imaging are used to detect and treat cancer: X-Ray X-Rays use electromagnetic waves to generate images of the inside of the body. Cancer screenings aim to detect cancer before symptoms appear.
Osteoporosis Osteoporosis is a disorder which affects the bones and is characterized by a progressive loss of bone tissue. This weakens bones making them porous, fragile, and susceptible to fractures. Osteoporosis is a common bonedisease with as many as 1.5
The diagnosis and management of intermediate-risk and high-risk prostate cancer are increasingly informed by advances in diagnostic imaging, the authors noted. "F-18 PSMA-1007 PET/CT provided improved accuracy compared with multiparametric MRI for prostate cancer tumor staging before radical treatment," the group wrote.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content